Ronald M. Sobecks

Ronald M. Sobecks

Transplant Surgery

9500 Euclid Avenue
Cleveland, OH 44195

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 120 publications

The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia.

The Prognostic Utility of Normal Karyotype Fraction in Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 11, 2026

Response to: "Comment on: risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors".

Response to: "Comment on: risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors".

Journal: Eye (London, England)

Published: May 08, 2026

Neighborhood Socioeconomic Disadvantage and Distance From Treatment Center do not Impact Survival Outcomes of Patients With Non-Hodgkin Lymphoma and Multiple Myeloma Treated With CAR T-Cell Therapies.

Neighborhood Socioeconomic Disadvantage and Distance From Treatment Center do not Impact Survival Outcomes of Patients With Non-Hodgkin Lymphoma and Multiple Myeloma Treated With CAR T-Cell Therapies.

Journal: Transplantation and cellular therapy

Published: April 17, 2026

Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion.

Myeloid/lymphoid neoplasm with FLT3 gene fusion: report of a case with a novel t(5;13)(q13;q12) SSBP2::FLT3 fusion.

Journal: Journal of hematopathology

Published: April 02, 2026

Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR-ABL1 transcript decline velocity in chronic myeloid leukemia: A 16-year real-world study.

Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR-ABL1 transcript decline velocity in chronic myeloid leukemia: A 16-year real-world study.

Journal: Cancer

Published: March 27, 2026

CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study.

CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study.

Journal: Blood advances

Published: September 08, 2025

CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.

CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study.

Journal: Blood advances

Published: September 08, 2025

Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors.

Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors.

Journal: Eye (London, England)

Published: August 21, 2025

Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60-75 Years: A Propensity Score-Adjusted Cohort Study.

Comparative Outcomes of Intensive Chemotherapy Versus Venetoclax Plus Hypomethylating Agents in Acute Myeloid Leukemia Patients Aged 60-75 Years: A Propensity Score-Adjusted Cohort Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: June 21, 2025

Impact of Cytogenetic Response to Therapy on Long-Term Survival in Acute Myeloid Leukemia.

Impact of Cytogenetic Response to Therapy on Long-Term Survival in Acute Myeloid Leukemia.

Journal: American journal of hematology

Published: May 19, 2025

Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.

Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.

Journal: Bone marrow transplantation

Published: April 16, 2025

Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative Neoplasms.

Myeloablative and Reduced Intensity Allogeneic Transplant in Patients with Myeloproliferative Neoplasms.

Journal: Hematology/oncology and stem cell therapy

Published: March 04, 2025

Showing 1-12 of 120

Last Updated: 09/26/2026